Congress funds school opioid prevention—with real accountability built in
H.R. 3130 — FACTS Act · Filed by Suzanne Bonamici (D-OR) · 9 cosponsors · Introduced May 1, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a federal grant program to help schools and public health agencies partner on preventing synthetic opioid misuse among teenagers, with up to 25 three-year grants funding education, training, peer counseling, and recovery programs. It also establishes an interagency task force to coordinate federal responses, amends education law to require schools to address opioid prevention in their plans, and expands federal data collection on youth synthetic opioid use and access.
Why we flagged it
The bill's core mechanism is a competitive grant program to schools and health agencies for evidence-based opioid prevention, education, and recovery services. It is a straightforward public health intervention with no deregulation, liability relief, or private subsidy.
What the text implies
- Naloxone purchase authority in school-based health centers may create liability questions if schools are expected to stock and administer the drug; the bill does not address immunity or training standards for school staff administering naloxone.
- The interagency task force includes bereaved parents and nonprofit representatives, which may create political pressure to prioritize certain prevention strategies over evidence-based ones if the task force's recommendations diverge from research.
The full analysis lists 3 implications of this text.
Who stands to gain
nonprofit organizations specializing in substance misuse prevention; school-based health centers; local and state educational agencies